Molecular Partners AG ADR Working Capital to Net Assets Ratio
Molecular Partners AG ADR working capital to net assets ratio. Molecular Partners AG ADR (MOLN) has a Working Capital to Net Assets ratio of 105.2% as of June 2026. Working capital of $61.39 Million (current assets of $71.18 Million minus current liabilities of $9.79 Million) is measured against net assets of $58.34 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check MOLN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Molecular Partners AG ADR (2013–2025)
Working capital to net assets ratio of Molecular Partners AG ADR from 2013 to 2025. This chart shows how Molecular Partners AG ADR's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 105.2%, reflecting working capital of $61.39 Million against net assets of $58.34 Million USD. See MOLN days of operational coverage to measure how many days the company can operate on defensive assets alone.
Molecular Partners AG ADR Working Capital to Net Assets Ratio by Year (2013–2025)
Molecular Partners AG ADR working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Molecular Partners AG ADR from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Molecular Partners AG ADR (MOLN) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 106.9% | $85.85 Million | $80.33 Million | $96.88 Million | $11.03 Million | ▲ +5.6 pp |
| 2024 | 101.3% | $143.50 Million | $141.64 Million | $154.28 Million | $10.79 Million | ▲ +0.4 pp |
| 2023 | 100.9% | $178.04 Million | $176.43 Million | $192.46 Million | $14.42 Million | ▼ -0.1 pp |
| 2022 | 101.0% | $237.50 Million | $235.17 Million | $254.75 Million | $17.25 Million | ▼ -8.4 pp |
| 2021 | 109.4% | $117.33 Million | $107.29 Million | $164.19 Million | $46.87 Million | ▼ -2.7 pp |
| 2020 | 112.1% | $120.14 Million | $107.22 Million | $177.81 Million | $57.67 Million | ▼ -19.7 pp |
| 2019 | 131.7% | $71.32 Million | $54.14 Million | $99.92 Million | $28.61 Million | ▲ +4.7 pp |
| 2018 | 127.0% | $116.45 Million | $91.70 Million | $153.32 Million | $36.87 Million | ▲ +17.0 pp |
| 2017 | 110.0% | $128.38 Million | $116.73 Million | $142.53 Million | $14.14 Million | ▼ -12.1 pp |
| 2016 | 122.1% | $165.79 Million | $135.79 Million | $181.56 Million | $15.77 Million | ▼ -3.4 pp |
| 2015 | 125.4% | $190.41 Million | $151.79 Million | $216.86 Million | $26.45 Million | ▲ +11.0 pp |
| 2014 | 114.4% | $169.86 Million | $148.48 Million | $191.96 Million | $22.10 Million | ▼ -61.6 pp |
| 2013 | 176.0% | $85.05 Million | $48.32 Million | $107.79 Million | $22.74 Million | — |